Fig. 3
From: Low expression of ACLY associates with favorable prognosis in acute myeloid leukemia
Knockdown of ACLY using the shRNA in THP-1 (a) and MOLM-13 (b) and the inhibitor SB-204990 in THP-1 (c) and MOLM-13 (d) cell lines
Fig. 3 | Journal of Translational Medicine
